SS

Settu Sharmila

Director Director DIN 08278165
DIN 08278165 First appointment Nov 2018 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Nov 2018
Shareholding value Locked Premium profile

About Settu Sharmila

Data last updated:

Settu Sharmila has 7 years in corporate governance. Formerly with 1 company, such as Nexmyra Biologics Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08278165
Primary Designation Director
First Appointment 13 Nov 2018
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Nexmyra Biologics Private Limited U74999KA2018PTC118457
Director13 Nov 20182018Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Nexmyra Biologics Private Limited
Premium access

Shareholding and investment profile for Settu Sharmila

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Settu Sharmila

Settu Sharmila has 7 years in corporate governance. Formerly with 1 company, such as Nexmyra Biologics Private Limited. Engaged in General Business. Contributes to corporate operations.

Settu Sharmila is associated with 0 companies as a director.

Settu Sharmila has expertise in General Business.

Settu Sharmila has 7 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available